1 COVID-19 - what should anaethesiologists and intensivists know about it?

2 COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.

3 Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China.

4 Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

5 Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship - Yokohama, Japan, February 2020.

6 Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?

7 WHO Declares COVID-19 a Pandemic.

8 Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature.

9 Containing COVID-19 among 627,386 Persons Contacting with Diamond Princess Cruise Ship Passengers Disembarked in Taiwan: Big Data Analytics.

10 Keeping the country positive during the COVID 19 pandemic: Evidence from India.

11 Straining the System: Novel Coronavirus (COVID-19) and Preparedness for Concomitant Disasters

12 Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

13 COVID-19: combining antiviral and anti-inflammatory treatments

14 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

15 Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

16 Impact of COVID-19 on people with cystic fibrosis

17 Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis

18 Low incidence of COVID-19 in children and adolescent post-liver transplant at a Latin American reference center

19 The COVID-19 Pandemic from an Ophthalmologist's Perspective

20 The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

21 A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features

22 COVID-19 and Nasal Cytobrush Cytology

23 Smell and taste dysfunction in patients with COVID-19

24 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

25 Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis

26 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

27 Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

28 Hydroxychloroquine prophylaxis for COVID-19 contacts in India

29 Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment

30 Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

31 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

32 COVID-19 versus SARS: A comparative review

33 A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

34 Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020

35 Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

36 A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview.

37 Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak

38 The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

39 Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?

40 Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy.

41 Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".

42 Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Integrated Computational Approach.

43 Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.

44 Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.

45 F-FDG uptake in Asymptomatic SARS-CoV-2 (COVID-19) patient, referred to PET/CT for Non-Small Cells Lung Cancer restaging.

46 Novel 2019 coronavirus SARS-CoV-2 (COVID-19): An updated overview for emergency clinicians

47 The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?

48 The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.

49 Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.

50 Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.

51 Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.

52 Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.

53 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

54 Stability and Viability of SARS-CoV-2. Reply.

55 Stability and Viability of SARS-CoV-2.

56 Stability and Viability of SARS-CoV-2.

57 Stability and Viability of SARS-CoV-2.

58 Stability and Viability of SARS-CoV-2.

59 Stability and Viability of SARS-CoV-2.

60 A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran.

61 Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense.

62 Clinical Trials during the SARS-CoV-2 Pandemic.

63 The evidence of SARS-CoV-2 infection on ocular surface.

64 [Obstetric Anesthesia During the SARS-CoV-2 Pandemic - a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees].

65 Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.

66 Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

67 Advanced forecasting of SARS-CoV-2 related deaths in Italy, Germany, Spain, and New York State.

68 Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

69 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

70 Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.

71 The Architecture of SARS-CoV-2 Transcriptome.

72 What do we know about the SARS-CoV-2 coronavirus in the environment?

73 Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient

74 Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2.

75 A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

76 Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol.

77 Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.

78 Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories

79 The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2

80 Properties of Coronavirus and SARS-CoV-2.

81 Exercise against SARS-CoV-2 (COVID-19): Does workout intensity matter? (A mini review of some indirect evidence related to obesity).

82 Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.

83 Treatment of SARS-CoV-2: How far have we reached?

84 Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions.

85 Perspective: SARS-CoV-2, COVID-19 and Haematologists.

86 Structure-based Virtual Screening and Molecular Dynamic Simulation Studies of the Natural Inhibitors of SARS-CoV-2 Main Protease

87 Delivery in pregnant women infected with SARS-CoV-2: A fast review.

88 Validation of SARS-CoV-2 detection across multiple specimen types.

89 A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).

90 Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?

91 Electron microscopy of SARS-CoV-2: a challenging task.

92 Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.

93 Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia.

94 Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection (Nature Communications, (2020), 11, 1, (2251), 10.1038/s41467-020-16256-y)

95 Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome

96 Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M<sup>pro</sup>

97 COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms

98 A human monoclonal antibody blocking SARS-CoV-2 infection

99 The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

100 Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

101 A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy

Keyword Connections

Journals

Research Groups

Bibliographies